In cancer, the immune system plays a crucial role in both tumor progression and response to treatment. A higher NLR typically indicates a systemic inflammatory response, which is often associated with poorer outcomes in various types of cancer. Elevated neutrophil levels can promote tumor growth and metastasis, while reduced lymphocyte levels may weaken the body's immune response to cancer cells.
